Personalized cancer therapy
This breakfast seminar organised by the UiO:Life Science project Personalized Cancer Therapy (PerCaThe) will discuss the future development of Cancer Precision Medicine and specifically how the field can move to implementation in clinical trials and next in clinical practice.
Registration form at the bottom of this web page.
Foyer / Mingling area, Ground Floor, Research Building, OUH Radiumhospitalet
0800–0805 Welcome and Scope of Meeting: Towards Precision Cancer Medicine Implementation
Prof. Kjetil Tasken, ICR, OUH
0805–0825 Establishment of Molecular profiling for Individual Treatment decisions in Early Breast Cancer – status and experience from the EMIT project
Prof. Bjørn Naume, Dept of Oncology, OUH
0825–0830 Questions & Comments
0830–0850 Using sequence analysis to inform cancer treatment choices
Prof. Eivind Hovig, ICR, OUH and Centre for Bioinformatics, IFI UIO
0850–0855 Questions & Comments
0855–0915 Personalized cancer therapy, Regulatory challenges
Bjørg Bolstad, CHMP member, Norwegian Medicines Agency
0915–0920 Questions & Comments
0920–0940 Law perspectives (In Norwegian)
Hvilke utfordringer gir innføring av persontilpasset kreftbehandling med hensyn på hvordan helsevesenet er innrettet i dag mhp lovverk, forskrifter og beslutninger i ulike organer som Beslutningsforum
Anne Kjersti Befring, Researcher, Dept. of Public and International Law, UiO
0940–0945 Questions & Comments
0945–1000 Summary by Kjetil Taskén
Partnership for Life 2019 hosted by the Pharmaceutical industry (LMI) starts at 1030.
The University of Oslo and the City of Oslo invite all participants of the Oslo Life Science Conference to attend a reception in Oslo City Hall at 17.30 after the main event of the Oslo Life Science Conference 11 February. Registration for this reception.